---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-038544"
form_type: "8-K/A"
ticker: "FLNA"
cik: "0001069530"
company_name: "FILANA THERAPEUTICS, INC."
filed_at: "2025-12-22T23:59:59+00:00"
generated_at: "2026-05-16T12:23:08.465599+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Cassava Sciences amends 8-K to report Dawn Bir appointed to Compensation Committee

## Summary
- Dawn C. Bir appointed to Compensation Committee effective December 18, 2025.
- Amendment to prior 8-K filed October 22, 2025 reporting her board appointment.
- No other changes to the original current report.

## SEC filing metadata
- accession: 0001437749-25-038544
- form_type: 8-K/A
- ticker: FLNA
- cik: 0001069530
- company_name: FILANA THERAPEUTICS, INC.
- filed_at: 2025-12-22T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1069530/000143774925038544/0001437749-25-038544-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1069530/000143774925038544/sava20251219_8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-038544
- JSON: https://secwatch.observer/filing/0001437749-25-038544.json
- Plain text: https://secwatch.observer/filing/0001437749-25-038544.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.